Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Jul 18, 2023

BUY
$211.93 - $241.33 $720,562 - $820,522
3,400 New
3,400 $74,000
Q3 2022

Oct 25, 2022

SELL
$204.81 - $262.19 $40,962 - $52,438
-200 Reduced 66.67%
100 $0
Q2 2022

Aug 04, 2022

SELL
$213.86 - $277.87 $11.2 Million - $14.6 Million
-52,400 Reduced 99.43%
300 $0
Q1 2022

Apr 14, 2022

BUY
$259.82 - $298.18 $9.93 Million - $11.4 Million
38,200 Added 263.45%
52,700 $90,000
Q4 2021

Jan 18, 2022

SELL
$271.6 - $314.21 $1.25 Million - $1.45 Million
-4,600 Reduced 24.08%
14,500 $373,000
Q2 2021

Jul 19, 2021

BUY
$251.87 - $278.14 $4.81 Million - $5.31 Million
19,100 New
19,100 $353,000
Q1 2021

Apr 26, 2021

SELL
$204.88 - $255.03 $409,760 - $510,060
-2,000 Closed
0 $0
Q4 2020

Jan 21, 2021

BUY
$186.91 - $214.42 $186,910 - $214,420
1,000 Added 100.0%
2,000 $2,000
Q3 2020

Oct 27, 2020

SELL
$167.03 - $201.3 $618,011 - $744,810
-3,700 Reduced 78.72%
1,000 $3,000
Q2 2020

Jul 22, 2020

SELL
$113.31 - $182.44 $67,986 - $109,464
-600 Reduced 11.32%
4,700 $21,000
Q1 2020

May 07, 2020

SELL
$104.32 - $195.28 $125,183 - $234,336
-1,200 Reduced 18.46%
5,300 $9,000
Q4 2019

Feb 06, 2020

SELL
$163.48 - $173.61 $228,872 - $243,054
-1,400 Reduced 17.72%
6,500 $221,000
Q3 2019

Oct 28, 2019

SELL
$159.77 - $178.1 $575,172 - $641,160
-3,600 Reduced 31.3%
7,900 $231,000
Q2 2019

Aug 09, 2019

BUY
$144.16 - $172.9 $360,400 - $432,250
2,500 Added 27.78%
11,500 $413,000
Q1 2019

May 10, 2019

BUY
$123.7 - $156.3 $1.11 Million - $1.41 Million
9,000 New
9,000 $90,000
Q4 2017

Jan 17, 2018

SELL
$147.99 - $163.95 $443,970 - $491,849
-3,000 Closed
0 $0
Q3 2017

Oct 17, 2017

BUY
$149.47 - $160.56 $448,410 - $481,680
3,000
3,000 $4,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.